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We have determined that HSV causes rapid and large increases in cell-cycle-regulated free E2F and S-phase p107/E2F
DNA binding activities in asynchronous cultures of C33A cells. Induction occurred by 4 hr postinfection and coincided with
the appearance of viral encoded immediate-early and delayed-early proteins, i.e., when viral DNA replication normally
commences. No increase in E2F activities occurred when cells were infected with viruses expressing mutant regulatory
proteins ICP4 or ICP27, or mutant replication proteins ICP8, pol or helicase, or when cells were infected with wild-type
virus in the presence of inhibitors of DNA synthesis. In contrast, ICP8 mutant-infected cells contained elevated amounts of
NFkB activity equivalent to WT virus, no induction of Sp1 relative to WT virus, and reduced ATF/CREB activity relative to
WT virus. Results of transient expression assays with E2F-responsive reporters indicated that the net effect of induction
of both active (free E2F) and repressive (p107/E2F) complexes was a decrease in AdE2 promoter activity and an increase
in c-myc promoter activity. Taken together these results suggest that HSV can cause unscheduled changes in the amount
and functional status of a cell-cycle-regulated transcription factor. These results are discussed in light of possible roles for
viral-induced alterations in E2F, especially as related to imposing or overriding cell-cycle checkpoints. q 1995 Academic
Press, Inc.
Following primary infection of mucosal epithelium, and contact of the heteromeric complex with a TAF within
TFIID. An alternative mechanism of IE gene regulation,HSV enters peripheral sensory nerve endings and estab-
which may have relevance during reactivation from la-lishes a latent infection in neurons of dorsal root ganglia.
tency, involves one or more cellular functions expressedInfrequently, reactivation of the latent genome is trig-
in G0/G1 which complement for the absence of ICP0-gered, productive replication ensues within neurons, and
mediated functions (Ralph et al., 1994). Though promot-progeny viruses are transported back to the epithelium
ers of DE genes contain upstream cis-acting sites forwhere subsequent rounds of replication occur (Roizman
cellular transcription factors such as Sp1 or CCAAT boxand Sears, 1990). Productive replication by HSV, as de-
binding proteins, induced expression of DE genes ap-fined in tissue culture models of asynchronously dividing
pears to only depend on the integrity of the TATA boxcells, is characterized by the temporal expression of pro-
and the IE regulatory protein ICP4. Expression of leaky-teins (Honess and Roizman, 1974) encoded among the
L (g1) genes does not stringently depend on viral DNAover 70 known genes of HSV (Chou and Roizman, 1986;
synthesis, though the normal transition from low expres-McGeogh et al., 1986, 1988). Conventionally, the kinetic
sion prior to DNA replication to maximal after the onsetclasses of viral genes and their functions are referred to
of DNA replication relies on TATA box and transcribedas immediate-early (IE or a) regulatory, delayed-early (DE
leader sequences (Huang et al., 1993). Efficient promoteror b) DNA replication, and late (L, or g1 and g2) structural
activity also depends on cis-acting upstream sequencesand assembly.
(Mills et al., 1994). Detectable expression of true L (g2)Induction of IE gene expression is well understood
genes depends on the onset of viral DNA synthesis. Pro-and involves interaction of a tegument component of the
moter elements which mediate regulated expression of Lvirion, VP16, with the cellular transcription factor OctI.
genes generally consist of a TATA box and downstream-This results in enhanced binding of the heteromeric com-
activating sequences (DAS), from near the transcriptionplex to cognate OctI DNA binding sites in IE promoters
start site and extending a variable distance into tran-
scribed nontranslated sequences of the genes. The na-
ture of trans-acting factors that bind to L gene promoter1 Present address: Dept. of Oncology, University of Wisconsin–Madi-
elements, though cellular in origin (Guzowski et al., 1994),son, Madison, WI 53706.
2 To whom reprint requests should be addressed. are currently unclear.
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In dividing cells, HSV DNA replication occurs as DE traub et al., 1992; Zamanian and LaThangue, 1992; Zhu et
proteins accumulate and coincident with inhibition of cel- al., 1993), while free E2F appeared to mediate promoter
lular DNA replication (Roizman and Roane, 1964). Infec- activation (Bagchi et al., 1989; Yee et al., 1989; Dynlacht
tion by HSV has also been shown to prevent cells that et al., 1994), and (iv) that overexpression of p107 or pRB
are in G1 from entering S phase (de Byrn Kops and Knipe, growth arrested cells in G1 , dependent on their ability to
1988). Based on the foregoing observations on regulation bind E2F (Hinds et al., 1992; Zhu et al., 1993). Thus E1A
of viral gene expression and effects on cell DNA synthe- could both activate a transcription factor critical for lytic
sis, it seemed reasonable to investigate whether HSV viral replication and alter the regulation of one or more
has a concerted effect on mechanisms which regulate cell-cycle checkpoints by disrupting protein–protein in-
cell-cycle progression. Altering these regulatory mecha- teractions normally regulated by cell-cycle-dependent
nisms might be expected to effect the functional state of phosphorylation of pRB. The transformation/replication
cellular transcription factors, the synthesis or activation proteins E7 of human papillomavirus (HPV) and T-Ag of
of replication/repair factors, or the synthesis of cellular SV40 also contain E1A CR-2-like domains critical for
DNA. To investigate alterations in cell-cycle-regulated binding to pRB and release of E2F (Chellappan et al.,
functions we chose to focus on the effects of HSV on 1992; Pagano et al., 1992).
the cellular transcription factor E2F. Because E2F forms complexes with other cellular pro-
E2F was first identified in studies of adenovirus E1A- teins in a cell-cycle-regulated fashion, it also represents
regulated gene expression, by virtue of its ability to bind a convenient marker for G0 , G1 , and S phases (Mudryj
to sites within the promoter of and to activate expression et al., 1991; Cobrinik et al., 1993; Schwarz et al., 1993).
of the Ad E2 gene (Kovesdi et al., 1986; Nevins, 1992). An E2F-4–p107 DNA binding complex containing cdk2
E2F is in fact a collection of heterodimeric transcription and cyclin E accumulates in G1 (Lees et al., 1992; Beijers-
factor complexes, each consisting of one of five distinct bergen et al., 1994; Ginsberg et al., 1994). This is followed
E2F family member subunits in combination with one by the appearance of a similar complex, containing cyclin
of two DP family member subunits (for a review, see A, at the G1/S boundary and persisting into S (Devoto etLaThangue, 1994). Cellular targets of E2F have been al., 1992; Schwarz et al., 1993). The induction of a com-
identified and include a number of genes implicated in plex similar if not identical to the S-phase-specific com-
cell-cycle progression whose normal expression is either plex has been described in CMV-infected cells (Wade
confined to G1 or otherwise associated with DNA replica- et al., 1992). A second type of cell-cycle-specific com-
tion during S phase. These include the myc and myb
plex, E2F–pRB, consisting primarily of E2F-1, -2, or
gene families, cyclin A, DHFR, thymidylate synthase,
-3/DP-1 heterodimers (Lees et al., 1993) was detected in
PCNA, DNA polymerase a, deoxycytidine kinase, and
serum-stimulated cells entering S phase (Mudryj et al.,cdc2 kinase (Nevins, 1992; DeGregori et al., 1995). At the
1991; Schwarz et al., 1993). A third type of activity, origi-same time, studies focusing on the mechanism of cellular
nally termed complex X (Chittenden et al., 1993) wastransformation mediated by adenovirus E1A had identi-
detectable during G0 and early G1 and represents E2F-4fied amino acid sequences within the E1A conserved
or -5/DP heterodimers (Hijmans et al., 1995; Vairo et al.,region 2 (CR2) as responsible for interaction with several
1995) in complex with the p107-related protein, p130 (Co-cellular proteins (Giordano et al., 1991; Harlow et al.,
brinik et al., 1993). Free forms of E2F begin accumulating1986; Pines and Hunter, 1990). Among these E1A-associ-
at the end of G1 and also persist into S phase (Schwarzated proteins were the product of the retinoblastoma
et al., 1993).susceptibility gene, pRB, a related protein p107 (Dyson
In light of findings summarized above, which identifiedet al., 1989; Whyte et al., 1988, 1989), cyclin A (Pines
E2F within cell-cycle-regulated heteromeric complexes,and Hunter, 1990), and the cyclin-regulated kinase, cdk2
studies were initiated to determine whether HSV infec-(Giordano et al., 1991; Hu et al., 1992; Lees et al., 1992).
tion alters the amount or type of E2F-dependent gel mo-An understanding of the relationship between replicative
bility shift activities and the functional status of E2F activ-and transforming functions of E1A occurred when it was
ity. We present results of experiments indicating that (1)demonstrated that (i) E2F–pRB complex formation was
HSV rapidly induces S-phase-specific E2F DNA bindingregulated by the phophorylation state of pRB (Cao et al.,
activities, (2) induction involves expression of at least1992; Chellappan et al., 1991; Chittenden et al., 1991;
three viral-encoded regulatory proteins whose commonShirodkar et al., 1992), (ii) that E1A could release and
target is viral DNA replication, and (3) the consequencetake the place of E2F in these complexes (Bagchi et al.,
of inducing both free (active) and heteromeric (repres-1990; Bandara and LaThangue, 1991; Chellappan et al.,
sive) E2F is dependent on the promoter context of the1991, 1992; Chittenden et al., 1991), (iii) that pRB or p107
E2F site. Possible reasons for unscheduled increases incould suppress E2F-responsive promoters (Arroyo and
free and S-phase E2F activities following HSV infectionRaychaudhuri, 1992; Flemington et al., 1993; Hamel et
al., 1992; Hiebert et al., 1992; Schwarz et al., 1993; Wein- will be discussed.
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MATERIALS AND METHODS mutations in the ATF site (ATF0), the pE2F site (pE2F0),
the pE2F, and ATF sites (ATF0pE2F0), or both E2F sites
Cells and virus (E2FX20).
C-33 A cells (ATCC HTB31) were derived from a human
E2F gel mobility assaycervical carcinoma and lack HPV sequences and ex-
press a mutated pRB (Scheffner et al., 1991). Monolayer DNA–protein complexes were formed in buffer con-
cultures were maintained in Dulbecco’s modified Eagle sisting of 20 mM HEPES, pH 7.6, 40 mM KCl, 0.1 mM
medium plus glucose (DMEM-H) supplemented with 10% EGTA, 1 mM EDTA, and 0.8 mM dithiothreitol. The com-
fetal calf serum. Herpes simplex virus type 1 (HSV-1) plete reaction mixture contained 2–3 mg of salmon
strain KOS and strain mutants were used at a multiplicity sperm DNA (Sigma), 20 1 103 cpm (approx 0.1 ng) of
of 5–10 plaque-forming units (PFU) per cell. Viral mu- end-labeled probe DNA, and 2–4 mg of protein extract
tants, and their properties are summarized in Table 1. in a total of 30 ml and was incubated for 20 min at room
temperature (rt). Monospecific or monoclonal antibodies
Preparation of cell extracts were assayed for their ability to either alter the mobility
of or disrupt complexes by preincubation with extract onNuclear extracts (Dignam et al., 1983) for gel mobility
ice for 20 min prior to addition of specific probe se-assays were prepared at 16 hr postinfection (p.i.), unless
quences and further incubation at rt for 20 min. The ef-otherwise indicated. Buffers used were supplemented
fects of disrupting protein–protein interactions on gelwith 1 mM each of protease inhibitors leupeptin and pep-
shift activities were determined by preincubating extractstatin. Nuclear extracts were also prepared by a rapid
for 20 min at 47 in 0.8% deoxycholate, followed by additionlysis protocol. Cells from a 100-mm dish were washed
of NP-40 to 1.2%. An aliquot of the treated extract wastwice with ice-cold PBS and resuspended in 200 ml of
added to a reaction mix containing probe DNA and fur-CE buffer (10 mM HEPES, pH 7.6, 1 mM EDTA, 60 mM
ther incubated for 20 min at rt. Aliquots of binding assaysKCl, 1 mM DTT, 0.1% NP-40, and a cocktail of inhibitors
were fractionated at 47 on nondenaturing 4% acrylamideconsisting of 1 mM PMSF, 0.4 mM NaF, 0.4 mM Na3VO4 ,
gels prepared in 0.251 TBE (11 TBE is 10 mM Tris10 mM leupeptin, and 10 mM pepstatin) and incubated
base, pH 8.3, 9 mM boric acid, 2 mM EDTA). Gels wereon ice for 4 min. Nuclei were pelleted at 1500 RPM in
transferred to 3MM paper, dried under vacuum and heat,the cold and washed once in CW buffer (identical to CE
and exposed to XAR film with intensifying screensbuffer but without NP-40). The cytoplasmic extract was
at 0707.incubated for 10 min on ice with 0.75% deoxycholate,
debris was removed by centrifugation at 12,000 RPM for
Detection of Sp1 and NFkB DNA binding activities10 min at 47, and the resulting supernatant was stored
at 0707. Nuclei were again pelleted at low speed in the Nuclear extracts were assayed for levels of NFkB and
cold and resuspended in 200 ml or less of NE buffer (20 Sp1 DNA binding activities exactly as described pre-
mM Tris–HCl, pH 8.0, 420 mM NaCl, 1.5 mM MgCl2 , viously (Baldwin et al., 1991; Yurochko et al., 1995). For
0.2 mM EDTA, 25% glycerol, and the inhibitor cocktail detection of NFkB, extracts were incubated with a radio-
containing 0.5 mM PMSF). Nuclei were incubated for 10 labeled probe containing the binding site from class I
min on ice with occasional mixing and then pelleted for MHC, TGGGGATTCCCCA, in buffer containing 10 mM
10 min at 15,000 RPM in the cold. The resulting superna- Tris–HCl (pH 7.9), 50 mM NaCl, 0.5 mM EDTA, 10% glyc-
tant was dialyzed for 2 hr at 47 against 20 mM HEPES, erol, 1 mM DTT, and 2 mg of poly(dIdC)•(dIdC). For detec-
pH 7.9, 75 mM KCl, 0.2 mM EDTA, 0.5 mM DTT, 10% tion of Sp1, extracts were incubated with a radiolabeled
glycerol, and the inhibitor cocktail containing 0.1 mM probe containing a wild-type GC box (CCTTTTTAAGGG-
PMSF. Dialyzed nuclear extract was spun at 10,000 RPM GCGGGGCTT), in a DNA binding buffer consisting of 10
in the cold to remove any precipitate and then stored mM Tris–HCl, 50 mM NaCl, 0.5 mM EDTA, 10% glycerol,
at 0707. 1 mM DTT, 7.5 mM MgCl2 , and 0.1 mg poly(dIdC)•(dIdC).
For detection of ATF/CREB activities, extracts were incu-
E2F probes bated with the E2FX20 Ad E2 probe under standard E2F
reaction conditions.Detection of E2F-dependent gel shift activities utilized
adenovirus E2 promoter sequences consisting of proxi-
Detection of proteins
mal and distal E2F binding sites (pE2F and dE2F) and a
binding site for the cellular transcription factor ATF (Fig. Aliquots of whole cell, cytoplasmic, or nuclear extracts
were denatured by boiling in sample buffer (Harlow and1A). Gel shift probes were labeled by a fill-in reaction at
a Bgl II site (030) and excised from E2 promoter–CAT Lane, 1988), electrophoresed on SDS–PAGE gels, and
electroblotted onto PVDF paper. After blocking in 3% milk,reporter constructs (Loeken and Brady, 1989) by diges-
tion at a XbaI site (085). Additional probes contained proteins were detected by incubation with polyclonal or
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monoclonal antibodies, secondary incubation with a pro- to induce E2F activities is described below.) The increase
in E2F-dependent gel shift activities coincided with maxi-tein A–horseradish peroxidase conjugate, and detection
on X-ray film by light emission from the oxidation of lumi- mum accumulation of immediate-early viral proteins ICP4
and -27, and the delayed early viral protein ICP8 andnol (DuPont NEN Renaissance).
with the first detectable accumulation of the early-late
protein ICP35. The identification of ICP27 was confirmedTransient expression assays
by failure to detect the protein in extracts of mutant d27-
Target plasmids in transient expression assays con- 1-infected cells. Identification of ICP8 was corroborated
tained the chloamphenicol acetyltransferase (CAT) gene by detection of a truncated ICP8 (arrow) in extracts from
fused to E2 wild-type or mutant promoter sequences as d301-infected cells. Overaccumulation of ICP4 and un-
described above (Loeken and Brady, 1989) or minimal deraccumulation of ICP35 in virus mutant extracts was
promoter sequences from the c-myc gene as described also consistent with the phenotypes of these viruses (see
previously (Mudryj et al., 1991). Monolayers of C-33A below and Table 1).
cells at 75–80% confluence were transfected by the cal-
cium phosphate procedure (Gorman et al., 1982) with 10
Free and heteromeric E2F complexesmg of plasmid DNA. After 24 hr, cells were either mock
are induced by HSVinfected or infected with virus and extracts prepared after
an additional 24 hr and assayed for CAT enzyme activity To determine the nature of E2F-dependent activities
(Gorman et al., 1982). induced by HSV, nuclear extract from infected cells was
incubated with a monoclonal antibody against cdk2 (Fig.
RESULTS 2A, lane 2), or monospecific rabbit antisera against cyclin
A and p107 (lanes 4 and 5) prior to addition of labeledE2F-dependent gel shift activities are induced after
probe DNA. Incubation with antibodies resulted in eitherHSV infection
supershifting or disruption of an activity designated p107/
E2F (band 1 in Fig. 1), identical to activities described asIn an initial experiment, we determined the effects of
HSV infection on E2F-dependent DNA binding activities appearing either at the onset of S phase (Cao et al.,
1992; Devoto et al., 1992; Shirodkar et al., 1992) or afteras a function of time postinfection. Replicate cultures of
C33-A cells were either mock infected or infected with infection with cytomegalovirus (Wade et al., 1992). In ad-
dition, a p130 antibody did not effect the mobility of anywild-type (WT) virus, and nuclear extracts were prepared
at times between 2 and 10 hr postinfection. At least 6 of the activities described here (M.J.H. and S.L.B., unpub-
lished observations). An increase in ‘‘free’’ E2F activity asdistinct gel shift bands are readily apparent. Compared
to uninfected cell extract, these gel shift activities had cells enter S phase has previously been noted (Schwarz
et al., 1993), and we observed an increase in two geldeclined by 2 hr p.i., increased dramatically between 2
and 4 hr p.i., and remained high throughout the remainder shift activities, E2F and E2FR (bands 3 and 4 in Fig. 1B)
that have properties of free E2F. First, both were unaf-of the time course (Fig. 1B, lanes 1–6). Bands NS and
NS-L were judged nonspecific since they were not com- fected by incubation with antibodies against p107, cyclin
A or cdk2, but were efficiently competed by an E2F oligo-peted by unlabeled oligonucleotide containing E2F bind-
ing sites (see Fig. 2), and persisted when the E2F sites nucleotide (lane 7). Second, the activity designated E2F
in Fig. 2 corresponded in mobility to free E2F detectedin the probe were mutated (Fig. 3A, lane 2). Although
these two bands were detected to variable extents in in cells infected with the adenovirus E4 mutant dl366
(S.B., unpublished observations). Third, these activitiesextracts, band NS was usually less apparent in infected
extracts, while the appearance of band NS-L was depen- were not detected with a DNA probe in which both E2F
sites were mutated (see below, Fig. 3). Experiments to bedent on viral late gene expression (see Fig. 4). Gel shift
activities 1–4 were further characterized (see below, presented below also indicate that detergent treatment of
extracts results in disruption of p107/E2F activity and anFig. 2).
To determine how the time of induction of E2F activi- increase in the amount of E2F but not of E2FR activity
(Fig. 3). Although we cannot exclude the possibility thatties compared to the temporal program of HSV gene
expression, samples of extracts were fractionated by E2FR is a breakdown product of E2F which still retains
DNA binding activity, it is more likely that E2F and E2FRSDS–PAGE, Western blotted, and probed with antibodies
to representative IE, DE, and L proteins (Fig. 1C). In addi- represent heterodimers of differing subunit composition
(Huber et al., 1993). The activity designated as band 2 intion, samples of extracts from cells infected with either
the ICP27 null mutant, d27-1 (Rice and Knipe, 1990), or Fig. 1 was competed when extract was incubated with
unlabeled E2F competitor DNA (Fig. 2, lane 7) but wasthe ICP8 deletion mutant, d301 (Gao and Knipe, 1989),
and harvested at 10 hr p.i. were assayed. (These and not affected by incubation with antibodies against p130
or E2F-4 (M.J.H. and S.L.B., unpublished observations),other mutants are described in Table 1, and their ability
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FIG. 1. Induction of E2F-dependent DNA binding activities by HSV. (A) E2F probe DNA: The adenovirus E2 promoter consists of a TATA-like
sequence, proximal and distal binding sites for E2F (pE2F and dE2F), and a binding site for ATF/CREB. Gel shift probes were labeled by linearization
and a fill-in reaction at a Bgl II site and excised from E2 promoter CAT reporter constructs (Loeken and Brady, 1989) by digestion at an XbaI site.
Additional probes used were mutated at the ATF site (ATF0), the pE2F site (pE2F0), the pE2F and ATF sites (ATF0pE2F0), or both E2F sites (E2FX20).
(B) Time course of induction: Gel mobility shifts of probe DNA after incubation with nuclear extracts prepared from uninfected (U, lane 1) C33 cells
or cells infected with HSV and harvested at times between 2 and 10 hr p.i. (lanes 2–6). The ATF0-end-labeled DNA probe was used in this and
all subsequent analyses unless otherwise noted. Designations to the left of the panel are explained in the text. (C) Time course of infected cell
protein accumulation: Nuclear extracts were fractionated by SDS–PAGE, electroblotted onto nitrocellulose, probed with monoclonal antibodies
(ICP4, ICP27, and ICP35) or polyclonal antibody (ICP8), and detected by an alkaline phosphatase detection system. Lanes 1–6, time course of WT
HSV-infected cells; lane 7, extract from 10-hr infection with the ICP27 mutant d27-1 (Table 1); lane 8, extract from 10-hr infection with the ICP8
mutant d301 (Table 1).
or when extracts were incubated with DOC (Fig. 3). Since
its precise nature remains obscure, we have designated
it as X.
Notable was the failure of the anti-cyclin A antibody
to completely affect the p107/E2F activity (Fig. 2A, lane
4). To determine the nature of this residual p107/E2F
activity and of the corresponding activity in uninfected
cell extracts, we compared the effects of cyclin E and
cyclin A antibodies on p107/E2F (Fig. 2B). The cyclin E
antibody largely eliminated the p107/E2F activity found in
the uninfected cell extract while only affecting the lower
portion of the activity detected in extracts from infected
cells (cf. lanes 2 and 6). In contrast, cyclin A antibody
had little detectable effect on p107/E2F from uninfected
cells, but eliminated the greater part, and slower mobility
component, of the infected cell p107/E2F activity (lanes
3 and 7). Incubation of either extract with both antibodies
eliminated all the p107/E2F activity (lanes 4 and 8). A
p107/E2F activity containing cdk2 and cyclin E has been
FIG. 2. Identification of E2F complexes induced by HSV. (A) Free described (Lees et al., 1992) as arising early in G1 , prior
E2F and p107/E2F complexes: Infected C33 nuclear extracts were pre- to the appearance of the p107 complex containing cyclinincubated with (lanes 2, 4, and 5) or without (lanes 1 and 3) specific
A at the G1/S phase boundary. We conclude that theantisera as indicated, or a 50-fold molar excess of E2F site competitor
p107/E2F activity induced by HSV corresponds largely ifDNA (lane 6), prior to incubation with labeled probe in a standard DNA
binding assay. Designations for E2F-specific activities are explained not exclusively to the late G1/S phase complex containing
in the text. (B) p107–cyclin E complex: Uninfected (lanes 1–4) and cyclin A, while the p107/E2F activity detected in unin-
HSV-infected (lanes 5–8) C33 extracts were preincubated with anti- fected cells contains largely cyclin E. This activity has
cyclin E (lanes 2 and 6), anti-cyclin A (lanes 3 and 7), or both antibodies
properties consistent with the E2FG1 complex described(lanes 4 and 8) prior to incubation with labeled probe DNA. p107/cE:
previously (Schwarz et al., 1993). Because C33A cellsp107/E2F activity containing cdk2/cyclin E; p107/cA: p107/E2F activity
containing cdk2/cyclin A. are RB0/0, we investigated the ability of HSV to induce
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sites (E2FX20, lane 2) were mutated. In contrast, detec-
tion of these activities did not depend on the presence
of both E2F sites acting in cis (pE2F0 and ATF0pE2F0,
lanes 3 and 4). Band X represents an E2F-dependent
activity with preference for the pE2F binding site, since
we could detect it in the absence of the ATF/CREB site
(lane 1) but not in the absence of both ATF and pE2F
sites (lane 4). Nearly coincident in mobility with complex
X is an ATF/CREB activity detectable in the absence of
the pE2F site (lanes 2 and 3). In a second experiment
(Fig. 3A, lanes 5–8), and in agreement with previously
published studies (Bagchi et al., 1989; Mudryj et al., 1991;
Wade et al., 1992), treatment with deoxycholate (DOC)
disrupted p107/E2F activities in both uninfected and in-
fected extracts and increased the amount of free E2F
DNA binding activity (Fig. 3A, lanes 5–8). E2FR persisted
but did not increase as a result of detergent treatment.
Two additional observations were made from this analy-
sis. First, a significantly greater increase in the amount
of free E2F DNA binding activity occurs in uninfected cell
extract as a result of detergent treatment than can be
accounted for by disruption of the p107/E2F activity. This
is consistent with previous results suggesting that E2F
may complex with one or more factors which prevent its
binding to DNA (Arroyo and Raychaudhuri, 1992). Alterna-
tively, the increase may reflect the reassortment, follow-
ing DOC disruption, of E2F and DP family members into
complexes with increased average DNA binding affinity.
FIG. 3. Properties of HSV induced E2F complexes. (A) Effect of DNA Second, the amount of free E2F detectable after DOC
binding site mutants and disruption of protein–protein complexes by
treatment increases after infection (compare lanes 6 andDOC on detection of gel shift activities: Infected cell nuclear extract
8) and this increase occurs with the same kinetics aswas incubated with end-labeled probe as indicated (lanes 1–4) in a
induction of E2F activities (Fig. 1B, and M.J.H. and S.L.B.,standard gel shift assay. Uninfected and infected extracts were either
untreated or treated with DOC as indicated (lanes 5–8) and described unpublished observations). We do not know if this in-
under Materials and Methods. Designations to the left are described crease results from changes in the amount of E2F, in the
in the text. (B) Effect of anti-E2F antibodies on gel shift activities: Sam-
ability of E2F complexes to reform after DOC treatment,ples of infected cell nuclear extract were mock incubated (lanes 1 and
or changes in E2F distribution within the cell.4) or incubated with increasing amounts of antibody (lanes 2, 3, and
Finally, the effect of three anti-E2F antisera on the E2F5–8) prior to a standard DNA binding reaction as described under
Materials and Methods. Antibodies and designations for gel shift activi- activities was determined. An antibody raised against the
ties are described in the text. C-terminal, RB binding domain of E2F (aE2FRB , Fig. 3B,
lanes 2 and 3), supershifted the E2F activity, while an-
other C-terminal antibody (aRBP3, lanes 5 and 6) inter-p107–E2F and pRB–E2F complexes in U20S and human
embryonic lung fibroblasts (HEL) containing a RB/// ge- fered with the free E2F formation. Both antibodies left
the E2FR activity largely intact. The inability of these anti-notype. In both cell types, both E2F heteromeric com-
plexes were induced as well as elevated levels of free bodies to disrupt p107/E2F is consistent with p107 com-
plexing with the carboxy-terminal portion of E2F. A thirdE2F (M. J. Hilton and S. L. Bachenheimer, unpublished
observations). antibody, apepA, with specificity for the amino-terminal
portion of murine DP1 (Girling et al., 1993), was able toWe performed a series of experiments to confirm that
the DNA gel shift activities detected after HSV infection partially disrupt p107/E2F, E2F, and E2FR . This result is
consistent with a report that DP-1 is present in a complexdepended on E2F. A gel shift analysis was performed
with probes (Loeken and Brady, 1989) containing clus- with p107 (Girling et al., 1993). Although apepA appeared
to diminish both E2F and E2FR activities, we do not knowtered point mutations in different combinations of tran-
scription factor binding sites found in the Ad E2 promoter whether E2FR is a heterodimer containing DP1 or a DP1-
related activity. None of the antibodies had an effect on(Fig. 1A). In comparison with our standard ATF0 probe
(Fig. 3A, lane 1), the ability of the probe to detect p107/ activity X. Taken together, these results indicate that gel
shift activities induced by HSV share properties of eitherE2F, X, E2F, and E2FR activities was lost when both E2F
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free E2F or of E2F heteromeric complexes previously
described as present during late G1 or S phase.
ICP4, ICP27, and ICP8 are necessary for E2F
induction by HSV
At least three IE proteins and one DE protein of HSV
affect the temporal program of gene expression. Genetic
dissection of IE ICP4 identified separable domains re-
quired for either binding to DNA and negative regulation
of IE promoters, or trans-activation of target DE and L
promoters (DeLuca and Schaffer, 1988). Viruses express-
ing mutant forms of IE ICP0 have reduced ability to ex-
press DE and L proteins in cells following low multiplicity
infection, and DNA from such mutants has drastically
reduced ability to establish infected cell foci after trans-
fection (Cai and Schaffer, 1989, 1992; Chen and Sil-
FIG. 4. Identification of HSV-encoded functions required for E2F in-verstein, 1992). Mutations in ICP27 have identified sepa-
duction. (A) ICP4 mutants: Samples of nuclear extract prepared from
rable functional domains with effects on DNA replication uninfected cells (lane 1) or virus-infected cells (lanes 2–6) as indicated
(Rice and Knipe, 1990; Rice et al., 1993), and the negative above the lanes were incubated in a standard DNA binding reaction.
(B) ICP27 and ICP8 mutants: Samples of nuclear extract prepared fromregulation of IE and DE gene expression and efficient
uninfected cells (lanes 1 and 5) or virus-infected cells (lanes 2–4 andexpression of L genes (McCarthy et al., 1989; Rice and
6–8) as indicated above the lanes were incubated in a standard DNAKnipe, 1990). One component of ICP27’s ability to posi-
binding reaction. Designations to the left of the panels are described
tively regulate L genes and negatively regulate IE and in the text and the properties of mutant viruses are listed in Table 1.
DE genes occurs at a posttranscriptional level (McCarthy
et al., 1989; McLaughlan et al., 1992; Sandri-Goldin and
Mendoza, 1992). The ability to ascribe a transcriptional tion-defective mutant of ICP4 (vi13, lane 5), and the levels
role for ICP27 in L gene expression has been compli- of other E2F-dependent activities appeared unchanged
cated by the drastic effect of ICP27 mutations on DNA or reduced relative to the uninfected extract. Results of
replication. Recent reports of Rice and Lam (1994) and infections with ICP8 and ICP27 mutants are presented
Hibbard and Sandri-Goldin (1995), however, indicate that in Fig. 4B. DNA replication-negative ICP8 mutants d301,
certain ICP27 mutants which support normal levels of n2, and n10 (lanes 4, 7 and 8) failed to induce E2F activi-
viral DNA replication have defects in late gene transcrip- ties relative to WT (lanes 2 and 6). The appearance of
tion. A DE protein, ICP8, has an obligatory role in viral NS-L nonspecific activity was consistent with leaky-late
DNA replication (Challberg, 1986; Conley et al., 1981), (g1) gene expression by ICP8 mutants (35, and Fig. 1C).
and in the formation of prereplicative sites and their sub- The ICP27 mutants d27-1 (lane 3) and n59r (S.L.B., unpub-
sequent conversion into replication compartments (de lished observations) also failed to induce E2F activities.
Bruyn Kops and Knipe, 1988). ICP8 also participates in These latter viruses either express no ICP27 or only the
negative regulation of IE genes (Godowski and Knipe, extreme amino-terminal portion of the protein.
1986), repression of L gene expression from parental
genomes (Godowski and Knipe, 1986), and the positive Viral DNA replication may represent the regulatory
regulation of L genes from progeny genomes (Gao and target of ICP4, ICP27, and ICP8 in E2F induction
Knipe, 1989).
Rapid induction of E2F activities following infection The onset of viral DNA synthesis requires the activity
of IE regulatory proteins ICP4 and ICP27 and DE DNAwith HSV (Fig. 1) suggested that expression of viral en-
coded proteins plays a role in this process. We have replication proteins, among them ICP8. Since ICP8 has
both regulatory and DNA replication functions, two seriesidentified three of these HSV regulatory proteins as re-
quired for induction by analyzing extracts from cells in- of experiments were performed to determine the role of
DNA replication in E2F induction. In the first, effects offected with mutant viruses (see Table 1 for mutant vi-
ruses and their properties, and Fig. 4). Expression of mutations in two additional DE replication proteins on
E2F induction were determined. Replicate cultures ofaltered forms of ICP4 which retain ability to regulate HSV
gene expression (n208, vi11), or the absence of ICP0 C33-A cells were infected with either WT KOS, or the
DNA replication-negative mutants d301, HP66, and B72.expression (dlx3.1), still resulted in p107/E2F, free E2F
and E2FR induction (Fig. 4A, lanes 3, 4, and 6). In contrast, Cultures were also infected with pairwise combinations
of ICP8, polymerase and helicase mutants, or mock in-induction was not observed after infection with a regula-
/ m4484$7558 10-26-95 14:41:16 viras AP-Virology
631INDUCTION OF E2F COMPLEXES BY HSV
hydroxyurea (HU) or phosphonoacetic acid (PAA) (Fig. 6,
Table 1). From these analyses we conclude that failure
to form a complete and functional prereplicative complex
or to initiate replication of viral DNA resulted in failure
to induce E2F.
True-late gene expression is not required for E2F
induction
Previous studies have established that failure to repli-
cate viral DNA results in reduced expression of the g1
leaky-late proteins and failure to express g2 true-late
proteins (reviewed in Roizman and Sears, 1990). To elimi-
nate the possibility that failure to induce E2F was related
to a failure to express one or more g2 proteins, we took
advantage of an ICP27 mutant, n504 (Table 1). This virus
expresses all but the carboxy-terminal 8 amino acids of
ICP27 and supports normal DNA replication and g1 gene
expression but not g2 gene expression (Rice and Knipe,
1990). The previously tested ICP27 mutants, n59r and
d27-1, are reported to be impaired in DNA replication but
support at least limited g1 protein synthesis. Gel shift
analyses were performed (Fig. 6) and induction of p107/
E2F was determined by noting the effects of cyclin A
antibody. Although the majority of p107/E2F complexes
detected in uninfected cells contained cyclin A (lanes 9
FIG. 5. Viral DNA replication mutants fail to induce E2F activities.
Nuclear extracts were prepared from replicate cell cultures, mock in-
fected, infected with wild-type or the individual mutant viruses or with
pairwise combinations of the mutants. (A) E2F-dependent gel shift anal-
yses were performed as described previously. (B) Samples of nuclear
extracts were fractionated by SDS–PAGE, electroblotted onto PVDF,
and probed for ICP8 and gC as described under Materials and Meth-
ods.
fected. The results of gel shift assays of extracts pre-
pared from infected cells are presented in Fig. 5A. Single
infections of all three mutants failed to induce E2F activi-
ties (lanes 3–5) while all pairwise infections resulted in
complementation for E2F induction (lanes 6–8). The abil-
ity to induce E2F correlated with L gene expression, and
thus indirectly DNA replication, as measured by accumu-
lation of the g2 protein, gC (Fig. 5B). It is unclear why
HP66-infected cells supported limited gC expression; the
ICP8 immunofluorescence staining pattern in HP66-in-
fected cells indicated the existence of punctate prerepli-
cative structures, identical to the pattern seen in WT-
infected cells in the presence of PAA (S. Knight and
S.L.B., data not shown; de Bruyn Kops and Knipe, 1988). FIG. 6. Effect of inhibition of DNA synthesis on E2F induction. Sam-
ples of nuclear extracts prepared from infected cells (lanes 1–8) orIn addition, the failure to induce E2F did not reflect a
uninfected cells (lanes 9 and 10) were either mock incubated (oddtrans-dominant negative effect of mutant ICP8, since
lanes) or incubated with anti-cyclin A monoclonal antibody (even lanes)coinfections of d301 with HP66 or B72 mutants restored
prior to a standard DNA binding reaction. PAA, phosphonoacetic acid-
E2F induction. Failure to induce E2F was also noted treated WT-infected cell extract; HU, hydroxyurea-treated, WT-infected
when extracts were prepared from cells infected with cell extract. Designations to the left of the panel are described in the
text.WT virus in the presence of DNA synthesis inhibitors
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TABLE 1
Herpes Simplex Virus Type 1 Mutants
HSV protein Mutant designation Genotype Mutant phenotype
ICP4 (1298 aa)a n208 (DeLuca and Schaffer, 1988)b Term. @ aa774 DNA binding//regulation/
vi11 (Shepard and DeLuca, 1991) ala-ala in @ aa274 DNA binding0/regulation/
vi13 (Shepard and DeLuca, 1991) cys-ser in @ aa338 DNA binding0/regulation0
ICP0 (775 aa) dlx3.1 (Sacks and Schaffer, 1987) Null Wild type
ICP27 (512 aa) d27-1 (Rice and Knipe, 1990) Null DNA syn0/reduced g1 , no g2
n504r (Rice and Knipe, 1990) Term. @ aa505 DNA syn//g/1 , no g2
n59r (Rice and Knipe, 1990) Term. @ aa60 DNA syn0/reduced g1 , no g2
ICP8 (1196 aa) d301 (Gao and Knipe, 1991) aal-264/aa932-1196 DNA syn0/reduced g1 , no g2
n2 (Gao and Knipe, 1991) Term. @ aa1033 DNA syn0/reduced g1 , no g2
n10 (Gao and Knipe, 1991) Term. @ aa1160 DNA syn0/reduced g1 , no g2
pol (1235 aa) HP66 (Marcy et al., 1990) lacZ insert, pol deletion DNA syn0/reduced g1 , no g2
Helicase (UL5, 882 aa) B72 (Zhu and Weller, 1992) lacZ insert, UL5 deletion DNA syn0/reduced g1 , no g2
a Size of HSV-infected cell protein (ICP) in amino acid residues.
b Reference.
and 10), elevated levels of all E2F-dependent complexes are not responsible for the observed changes. It was of
were observed in the WT virus extract (lanes 1 and 2). interest therefore to determine how infection may have
Induction of E2F activities was observed in the n504r effected the levels of other transcription factors relative
extract (lanes 7 and 8), while little or no changes in the to E2F. Elevated amounts of NFkB-site binding activities
amount of p107/E2F, E2F, and E2FR activities were evi- have been observed following infection of human embry-
dent in extracts from cells infected with WT virus in the onic lung (HEL) and HeLa cells following HSV infection
presence of PAA (lanes 3 and 4) or HU (lanes 5 and 6) (Gimble et al., 1988; Rong et al., 1992). HSV-1 has also
when compared to uninfected cell extract. The effective- been reported to stimulate the HIV LTR through both
ness of the HU and PAA treatments in reducing g1 gene NFkB and Sp1 sites (Margolis et al., 1992), although no
expression was confirmed by Western blot analysis for g1 changes in Sp1 DNA binding activity by either gel retar-
proteins VP16 and ICP35 (M.J.H. and S.L.B., unpublished dation or exonuclease protection assays were observed
observations). (Gimble et al., 1988). Levels of these DNA binding activi-
The similar mobility of uninfected cell and infected cell ties, as well as ATF/CREB transcription factor, were de-
E2F activities, coupled with the failure of monoclonal termined by the gel shift assay. Nuclear extracts were
antibodies against ICP4 and ICP27 or a polyclonal anti- prepared from mock, wild-type, d301 (ICP8) and either
body against ICP8 to alter the mobility or disrupt any of d1-2-infected or n59r (ICP27)-infected C33A cells and
the E2F-dependent DNA binding activities (M.J.H. and assayed for levels of NFkB, Sp1, and ATF/CREB using
S.L.B., unpublished observation), suggest that ICP4, probes containing cognate factor binding sites (see Ma-
ICP27, and ICP8 are not physically associated with the terials and Methods). The results presented in Fig. 7
complexes. We conclude that an induction mechanism confirm previous reports of elevated NFkB activity and a
requiring the function of the regulatory proteins ICP4 and slight increase in Sp1 activity, but revealed little or no
27, and the onset of viral DNA replication, is required for change in ATF/CREB as a result of wild-type infection.
E2F induction. Since these proteins have distinct func- The identity of the NFkB activity was confirmed by the
tional targets within the regulatory cascade of viral gene ability of both p50 and p65 monoclonal antibodies to
expression, as well as a common target in regulating or supershift the gel shift bands (A. S. Baldwin and S.L.B.,
participating in viral DNA replication, it remains possible unpublished observations). Of particular interest was the
that additional viral genes responsive to ICP4, -27, or the ability of d301 to support an increase in NFkB but not
onset of viral DNA replication, e.g., efficient expression of E2F or Sp1 gel shift activities, and to cause a reduction
g1 proteins, may contribute to the E2F induction process. in the amount of ATF/CREB. The ICP27 mutants caused
Based on results with n504r, however, expression of g2 either a minimal increase in NFkB, consistent with a
genes is not required for E2F induction. previous report (Golden et al., 1992) or a decrease in
ATF/CREB. Taken together these results suggest that
Infection by HSV differentially effects cellular infection differentially effects DNA binding activities of
transcription factors Sp1, NFkB, and ATF/CREB several additional transcription factors dependent on the
functional status of viral encoded regulatory proteins andThe failure of certain HSV mutants to induce E2F activi-
ties argues strongly that nonspecific effects of infection in a pattern distinct from that of E2F.
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CREB having a major role in promoter activation and being
unaffected by viral infection (see Fig. 7).
Also presented in Fig. 8 are results with a second
set of CAT reporters containing minimal P2 promoter
sequences from the c-myc gene (Mudryj et al., 1990),
one of the normal cellular targets of E2F. In these report-
ers both upstream (divergent) and downstream (near
consensus) E2F sites were either intact (pMyc) or mu-
tated (pMycx). In addition, this promoter contains a Sp1
site just upstream of the near consensus E2F site, and
was intact in both reporters. Both constructs were in-
duced approximately twofold following HSV infection,
and there was significantly greater constitutive and in-
duced activity in the absence of E2F sites. Assuming that
basal expression from the c-myc promoter represents the
net effects of both E2F and Sp1 sites, our interpretation of
FIG. 7. Levels of Sp1, NFkB, and ATF/CREB DNA binding activities these results is that Sp1 has the primary role in mediating
following HSV infection. Nuclear extracts prepared from mock-, WT-, activated promoter function, and that elevated Sp1 activ-
or mutant virus-infected cells were assayed for transcription factors ity (Fig. 7) following infection overcomes effects of ele-
using DNA probes containing cognate binding sites, as described un-
vated p107/E2F. The basis for increased basal expres-der Materials and Methods. Bracket identifies NFkB-specific activities
sion from the pMycx even in the absence of functionalas determined by oligonucleotide competition and antibody sensitivity
(data not shown); only the upper four gel shift bands represent ATF/ pRB may indicate that most of the E2F activity that nor-
CREB activities as determined by oligonucleotide competition (data not mally binds this promoter in C33A cells is bound to p107,
shown). resulting in repressor function.
Activity of E2F-responsive promoters following HSV DISCUSSION
infection
The mechanism of HSV-induced alterations to E2F
Heteromeric E2F complexes containing p107 or pRB are activities
reported to be functionally repressive rather than inactive,
while free E2F is functionally active (Bagchi et al., 1989; We have presented evidence that HSV can induce
forms of E2F DNA binding activity which are normallyYee et al., 1989; Arroyo and Raychaudhuri, 1992; Hamel et
al., 1992; Hiebert et al., 1992; Weintraub et al., 1992; Zaman- seen late in G1 and at the G1/S phase boundary, namely
p107/E2F and free E2F (Figs. 1 and 2). The inductionian and LaThangue, 1992; Flemington et al., 1993; Schwarz
et al., 1993). Experiments were designed to determine process was rapid and depended on expression of func-
tional forms of the viral encoded proteins ICP4 and 27,whether and how HSV-induced increases in both these
E2F activities correlated with the activity of two sets of E2F- and replication proteins such as ICP8, polymerase, and
UL5 (Figs. 4 and 5). Genetic analyses of IE ICP4 and 27responsive CAT reporter genes. The first contained Ad E2
promoter sequences (Fig. 1, and Loeken and Brady, 1989), and DE ICP8 have defined positive roles for these pro-
teins in the expression of viral genes as well as the onseteither intact (WT) or mutated in either the ATF site (ATF0,
from which the probe used in our gel shift studies was of viral DNA replication. A simple interpretation of our
studies with viral mutants is that ICP4 and ICP27 arederived [see Figs. 1A and 3A]) or both E2F sites (E2FX20).
All three AdE2-based reporters exhibited comparable con- required because of their role in regulating the expres-
sion of delayed-early proteins, among them, ICP8. Thestitutive activity (Fig. 8), and both WT (containing ATF/CREB
and E2F sites) and E2FX20 (containing only the ATF/CREB latter, in turn, plays a critical role both in DNA replication
(Conley et al., 1981; Challberg, 1986; de Bruyn Kops andsite) reporters evidenced little change in activity following
infection. The ATF0 reporter (containing only E2F sites) Knipe, 1988) and the regulation of L, primarily g2 , gene
expression (Gao and Knipe, 1991). By immunofluores-however demonstrated as much as an eightfold repression
following infection by HSV. These results are consistent cence staining, ICP8 has been colocalized in nuclei with
both pRB and p53 (Wilcock and Lane, 1991). Other stud-with a model in which the E2F sites are mediating repres-
sion, to a large degree in the absence of an ATF site (ATF0) ies using similar experimental approaches have also lo-
calized ICP8 in prereplicative compartments which alsoand less so in its presence (WT), due to the increase in
p107/E2F activity following superinfection. The fact that pro- stain for areas of active cellular DNA synthesis (de Bruyn
Kops and Knipe, 1988), and later during the infectiousmoter activity of E2FX20 is elevated relative to the other
constructs following superinfection is consistent with ATF/ cycle with replicative proteins of the virus (Bush et al.,
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ucts of the viral E2 gene (Nevins, 1992). Since the do-
mains of E1A, LTAg, and E7 proteins responsible for
disrupting pRB/E2F also are critical for the transforming
ability of these DNA tumor viruses, the oncogenic proper-
ties of these viruses may stem largely from their ability
to disrupt cyclical interactions between transcription fac-
tors and tumor suppressor gene products. The induction
of p107/E2F or pRB/E2F by these viruses has not yet
been reported, but would not be inconsistent with induc-
tion of free E2F (this report and Kovesdi et al., 1986;
Nevins, 1992; Schwarz et al., 1993). Nor would it be incon-
sistent with their ability to induce S phase, or at the very
least to disrupt normal cell cycle regulation. One could
imagine, for example, that the transition to S phase re-
quires certain E2F-responsive genes, and thus their cog-
nate E2Fs, be activated, while other E2F-responsiveFIG. 8. Activity of E2F-responsive promoters following HSV infection.
Duplicate cultures of C33 cells were transfected with each reporter genes and their cognate E2Fs would be rendered inac-
gene by the calcium phosphate precipitation technique and 24 hr later tive.
either mock infected or infected with HSV. Following 24 hr of infection, The ability to displace E2F from p107 or pRB is a
whole cell extracts were prepared and equal amounts of protein were
common property of the DNA virus oncoproteins. In con-assayed for CAT activity as described under Materials and Methods.
trast, CMV infection of normal human fibroblasts resultsReporter genes contained promoter sequences from either the Ad E2
gene or the c-myc gene as described in the text. Each bar represents in elevated levels of the p107/cyclinA complex without
the average and standard error for at least three independent experi- affecting levels of free E2F (Wade et al., 1992). HSV in-
ments. Striped bars, constitutive (mock-infected) activity; filled bars, duces both free E2F and p107/E2F (this report) as well
infected cell activity.
as pRB/E2F in normal diploid fibroblasts and U2OS cells
(M. J. Hilton and S. L. Bachenheimer, unpublished obser-
vations). The ability of nuclear replicating DNA viruses to1991). As a consequence of initiating viral DNA replica-
alter the activity of E2F or its interactions with regulatorytion, the ability of pRB, p107, or E2F to form protein–
proteins likely reflects a common requirement for cellularprotein or protein–DNA interactions may be altered, thus
functions activated in late G1 or at the G1/S phase bound-affecting the cell cycle status of the cell and the distribu-
ary, and presumably involved in DNA replication. Viral-tion and amount of E2F complexes. Several mechanisms
specific effects on E2F likely reflect differences in thecan be envisioned for these alterations: (i) the localization
pathobiology of each of these viruses.of the replication proteins into discrete nuclear sites and/
or alterations in nuclear structure resulting from DNA
replication; (ii) phosphorylation of E2F, which regulates A role for G1-phase-activated cellular functions in
its interactions with pRB and p107 and with DNA (Bagchi HSV replication
et al., 1989; Buchkovich et al., 1989; Chellappan et al.,
HSV encodes both cis-regulatory and trans-acting fac-1991; DeCaprio et al., 1992; Dynlacht et al., 1994; Krek
tors necessary for viral DNA replication. These includeet al., 1994; Suzuki-Takahashi et al., 1995) may be tar-
origins of DNA replication and seven proteins whichgeted by g1 functions whose levels in turn are regulated
serve as components of the replication machinery (Chal-by the onset of DNA replication; and (iii) the regulation
lberg, 1986). While viral encoded replication proteins mayof specific g1 target genes by ICP27 (Rice and Knipe,
be sufficient to promote limited or early phases of DNA1990; Rice et al., 1989, 1993) may affect E2F localization,
replication, additional factors required for normal ge-interactions with other proteins, or binding to DNA.
nome replication likely need to be supplied by the cell
(Challberg and Kelly, 1989). One mechanism for ensuringComparison of herpesvirus and DNA tumor virus
that cell-encoded replication factors are available forinfection on E2F DNA binding activities
high level viral DNA replication would be to promote
G1 cell cycle events. Papova- and adenoviruses, whichAdenoviruses, papovaviruses, and papillomaviruses
disrupt or modify pRB/E2F complexes as a consequence encode no or a limited number of DNA replication func-
tions, respectively, rapidly induce unscheduled cellularof their strategies for establishing permissive conditions
for viral DNA replication. In addition, free E2F in a com- DNA replication after infection (reviewed by Challberg
and Kelly, 1989) in order to supply the factors requiredplex with one of the adenovirus E4 proteins positively
regulates expression of the DNA polymerase, single- for their own DNA replication. Herpes simplex virus, in
contrast, rapidly inhibits DNA replication after infectionstranded DNA binding protein, and terminal protein prod-
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of asynchronously growing cell cultures (Roizman and the virus promotes G0 to G1 progression with the resulting
expression or activation of G1 functions followed by effi-Roane, 1964) and prevents cells infected in the G1 phase
from entering S phase (de Bruyn Kops and Knipe, 1988). cient DNA replication.
Our results on the functional consequences of induc-The apparently contradictory needs for late G1 functions
for DNA replication and a complete and functional viral tion of both active and repressive forms of E2F DNA
binding activities (Fig. 8) lend support to an alterationDNA replication machinery in order to see E2F induction
can be reconciled by proposing that only early steps or in cell cycle status especially with regard to the c-myc
promoter construct. This is clearly a complex area foran early phase of viral DNA replication can occur prior
to changes in cell cycle status as represented by E2F investigation since the E2F-responsive, adenovirus E2
promoter was repressed in response to HSV infection.induction, and that complete and high level DNA replica-
tion requires both promoting G1 events and preventing These apparently disparate results could easily reflect
differences in the promoter contexts of the reportertransition of the G1/S phase boundary. The block in G1
to S phase progression and induction of elevated levels genes. The combinatorial nature of the subunit structure
of E2F is also a complicating factor since at present theof E2F complexes containing p107 by HSV are in fact
reminiscent of the G1 arrest imposed as a result of ec- precise nature of the E2F factor responsible for normal
regulation of any E2F target gene is unknown. E2F partic-topic overexpression of p107 or pRB (Hinds et al., 1992;
Zhu et al., 1993). ipates in the positive and negative regulation of cell cycle
progression genes and other genes expressed duringReplication during the acute phase of infection of dor-
sal root ganglia and reactivation from latency by HSV G1 and S phase (LaThangue, 1994; Nevins, 1992), making
it a convenient and informative indicator of more globaloccurs in terminally differentiated postmitotic neurons.
Since the G0 environment of the neuron is generally not changes occurring during the G1 to S phase transition.
Thus the rapid and unscheduled increases in free E2Fthought capable of supporting DNA replication, it seems
reasonable to suggest that HSV may promote exit from and p107/E2F activities observed after HSV infection may
reflect mechanisms for creation of a mid- to late-G1 envi-G0 , allowing reentry and progression through G1 , per-
haps as far as the R (restriction) point (for a review, see ronment, optimal for viral DNA replication, and preclud-
ing cell DNA replication.Weinberg, 1995). This in turn would lead to expression
or activation of cellular functions, normally required for We cannot exclude the possibility at this time that E2F
has a direct role in the regulated expression of HSVchromosomal DNA replication, but now redirected to-
ward efficient replication of viral DNA. A model for regula- genes. Our future investigations will be directed toward
this point as well as toward functional consequences oftion of viral gene expression during latency (Kosz-Vnen-
chak et al., 1993) was proposed to explain the reduced HSV infection for E2F-responsive cellular genes, identi-
fying any additional viral encoded proteins in the induc-expression of IE and DE genes in trigeminal neurons,
when viral DNA replication was impaired. The authors tion pathway, and determining whether cyclin-dependent
kinase activities are altered after infection.suggested at least two possible mechanisms to explain
the requirement for viral DNA replication in order to
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